The World Health Organization Disability Assessment Schedule-2.0 (WHODAS 2.0) in a chronic pain population being considered for chronic opioid therapy

Kelly M Wawrzyniak,1,2 Matthew Finkelman,3 Michael E Schatman,1,4 Ronald J Kulich,1,2 Valerie F Weed,5 Eura Myrta,1 David J DiBenedetto1,21Boston PainCare Center, Waltham, MA 02451, USA; 2Department of Diagnostic Sciences, Tufts University School of Dental Medicine, Boston, MA 02111, USA; 3Division...

Full description

Bibliographic Details
Main Authors: Wawrzyniak KM, Finkelman M, Schatman ME, Kulich RJ, Weed VF, Myrta E, DiBenedetto DJ
Format: Article
Language:English
Published: Dove Medical Press 2019-06-01
Series:Journal of Pain Research
Subjects:
Online Access:https://www.dovepress.com/the-world-health-organization-disability-assessment-schedule-20-whodas-peer-reviewed-article-JPR
_version_ 1818965923860578304
author Wawrzyniak KM
Finkelman M
Schatman ME
Kulich RJ
Weed VF
Myrta E
DiBenedetto DJ
author_facet Wawrzyniak KM
Finkelman M
Schatman ME
Kulich RJ
Weed VF
Myrta E
DiBenedetto DJ
author_sort Wawrzyniak KM
collection DOAJ
description Kelly M Wawrzyniak,1,2 Matthew Finkelman,3 Michael E Schatman,1,4 Ronald J Kulich,1,2 Valerie F Weed,5 Eura Myrta,1 David J DiBenedetto1,21Boston PainCare Center, Waltham, MA 02451, USA; 2Department of Diagnostic Sciences, Tufts University School of Dental Medicine, Boston, MA 02111, USA; 3Division of Biostatistics and Experimental Design, Tufts University School of Dental Medicine, Boston, MA 02111, USA; 4Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA 02111, USA; 5Primary Care Psychology Associates, LLC, Northbrook, IL 60062, USAPurpose: To examine the validity of the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) for the assessment of function in a community-based sample of patients with chronic pain conditions undergoing evaluation for chronic opioid therapy. Patients and methods: One hundred nine of 124 patients were evaluated for a chronic opioid therapy program between December 1, 2014 and April 10, 2015, inclusive, at one community-based interdisciplinary pain management practice. Measures included: demographic data; the WHODAS 2.0; a modified version of the Roland Morris Disability Questionnaire (RMDQ-m); the Patient Health Questionnaire-9 item (PHQ-9); the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R); the Current Opioid Misuse Measure (COMM), the Opioid Risk Tool (ORT); opioid dose. These data were collected as part of routine care, and this retrospective chart review study examined the data from this convenience sample, comparing the results of each assessment tool to the results of the WHODAS 2.0. Results: Median score on the WHODAS 2.0 was 25.69 (IQR=16.01 to 35.28). WHODAS 2.0 score was significantly correlated with the RMDQ-m (rs=0.69, p<0.001), the PHQ-9 (rs=0.68, p<0.001), the COMM (rs=0.52, p<0.001) and the SOAPP-R (rs=0.51, p<0.001). There was no significant correlation between the WHODAS 2.0 and the ORT (rs=0.14, p=0.12) or opioid dose (rs=0.07, p=0.47)Conclusions: The WHODAS 2.0 was significantly positively correlated with other measures, including measures of disability, risk of opioid misuse, and depression among patients being evaluated for chronic opioid therapy. The WHODAS 2.0 may be a useful measure of disability across a number of important domains when discussing expectations of both patients and providers at initiation of opioid therapy for chronic pain management. This assessment and discussion is crucial, particularly given the focus on function, rather than analgesia alone, when evaluating the effectiveness of opioid treatment.Keywords: disability, chronic pain, opioids, function
first_indexed 2024-12-20T13:24:43Z
format Article
id doaj.art-63587b1fca4c432586d7b676054b59ad
institution Directory Open Access Journal
issn 1178-7090
language English
last_indexed 2024-12-20T13:24:43Z
publishDate 2019-06-01
publisher Dove Medical Press
record_format Article
series Journal of Pain Research
spelling doaj.art-63587b1fca4c432586d7b676054b59ad2022-12-21T19:39:18ZengDove Medical PressJournal of Pain Research1178-70902019-06-01Volume 121855186246382The World Health Organization Disability Assessment Schedule-2.0 (WHODAS 2.0) in a chronic pain population being considered for chronic opioid therapyWawrzyniak KMFinkelman MSchatman MEKulich RJWeed VFMyrta EDiBenedetto DJKelly M Wawrzyniak,1,2 Matthew Finkelman,3 Michael E Schatman,1,4 Ronald J Kulich,1,2 Valerie F Weed,5 Eura Myrta,1 David J DiBenedetto1,21Boston PainCare Center, Waltham, MA 02451, USA; 2Department of Diagnostic Sciences, Tufts University School of Dental Medicine, Boston, MA 02111, USA; 3Division of Biostatistics and Experimental Design, Tufts University School of Dental Medicine, Boston, MA 02111, USA; 4Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA 02111, USA; 5Primary Care Psychology Associates, LLC, Northbrook, IL 60062, USAPurpose: To examine the validity of the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) for the assessment of function in a community-based sample of patients with chronic pain conditions undergoing evaluation for chronic opioid therapy. Patients and methods: One hundred nine of 124 patients were evaluated for a chronic opioid therapy program between December 1, 2014 and April 10, 2015, inclusive, at one community-based interdisciplinary pain management practice. Measures included: demographic data; the WHODAS 2.0; a modified version of the Roland Morris Disability Questionnaire (RMDQ-m); the Patient Health Questionnaire-9 item (PHQ-9); the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R); the Current Opioid Misuse Measure (COMM), the Opioid Risk Tool (ORT); opioid dose. These data were collected as part of routine care, and this retrospective chart review study examined the data from this convenience sample, comparing the results of each assessment tool to the results of the WHODAS 2.0. Results: Median score on the WHODAS 2.0 was 25.69 (IQR=16.01 to 35.28). WHODAS 2.0 score was significantly correlated with the RMDQ-m (rs=0.69, p<0.001), the PHQ-9 (rs=0.68, p<0.001), the COMM (rs=0.52, p<0.001) and the SOAPP-R (rs=0.51, p<0.001). There was no significant correlation between the WHODAS 2.0 and the ORT (rs=0.14, p=0.12) or opioid dose (rs=0.07, p=0.47)Conclusions: The WHODAS 2.0 was significantly positively correlated with other measures, including measures of disability, risk of opioid misuse, and depression among patients being evaluated for chronic opioid therapy. The WHODAS 2.0 may be a useful measure of disability across a number of important domains when discussing expectations of both patients and providers at initiation of opioid therapy for chronic pain management. This assessment and discussion is crucial, particularly given the focus on function, rather than analgesia alone, when evaluating the effectiveness of opioid treatment.Keywords: disability, chronic pain, opioids, functionhttps://www.dovepress.com/the-world-health-organization-disability-assessment-schedule-20-whodas-peer-reviewed-article-JPRdisabilitychronic painopioidsfunction
spellingShingle Wawrzyniak KM
Finkelman M
Schatman ME
Kulich RJ
Weed VF
Myrta E
DiBenedetto DJ
The World Health Organization Disability Assessment Schedule-2.0 (WHODAS 2.0) in a chronic pain population being considered for chronic opioid therapy
Journal of Pain Research
disability
chronic pain
opioids
function
title The World Health Organization Disability Assessment Schedule-2.0 (WHODAS 2.0) in a chronic pain population being considered for chronic opioid therapy
title_full The World Health Organization Disability Assessment Schedule-2.0 (WHODAS 2.0) in a chronic pain population being considered for chronic opioid therapy
title_fullStr The World Health Organization Disability Assessment Schedule-2.0 (WHODAS 2.0) in a chronic pain population being considered for chronic opioid therapy
title_full_unstemmed The World Health Organization Disability Assessment Schedule-2.0 (WHODAS 2.0) in a chronic pain population being considered for chronic opioid therapy
title_short The World Health Organization Disability Assessment Schedule-2.0 (WHODAS 2.0) in a chronic pain population being considered for chronic opioid therapy
title_sort world health organization disability assessment schedule 2 0 whodas 2 0 in a chronic pain population being considered for chronic opioid therapy
topic disability
chronic pain
opioids
function
url https://www.dovepress.com/the-world-health-organization-disability-assessment-schedule-20-whodas-peer-reviewed-article-JPR
work_keys_str_mv AT wawrzyniakkm theworldhealthorganizationdisabilityassessmentschedule20whodas20inachronicpainpopulationbeingconsideredforchronicopioidtherapy
AT finkelmanm theworldhealthorganizationdisabilityassessmentschedule20whodas20inachronicpainpopulationbeingconsideredforchronicopioidtherapy
AT schatmanme theworldhealthorganizationdisabilityassessmentschedule20whodas20inachronicpainpopulationbeingconsideredforchronicopioidtherapy
AT kulichrj theworldhealthorganizationdisabilityassessmentschedule20whodas20inachronicpainpopulationbeingconsideredforchronicopioidtherapy
AT weedvf theworldhealthorganizationdisabilityassessmentschedule20whodas20inachronicpainpopulationbeingconsideredforchronicopioidtherapy
AT myrtae theworldhealthorganizationdisabilityassessmentschedule20whodas20inachronicpainpopulationbeingconsideredforchronicopioidtherapy
AT dibenedettodj theworldhealthorganizationdisabilityassessmentschedule20whodas20inachronicpainpopulationbeingconsideredforchronicopioidtherapy
AT wawrzyniakkm worldhealthorganizationdisabilityassessmentschedule20whodas20inachronicpainpopulationbeingconsideredforchronicopioidtherapy
AT finkelmanm worldhealthorganizationdisabilityassessmentschedule20whodas20inachronicpainpopulationbeingconsideredforchronicopioidtherapy
AT schatmanme worldhealthorganizationdisabilityassessmentschedule20whodas20inachronicpainpopulationbeingconsideredforchronicopioidtherapy
AT kulichrj worldhealthorganizationdisabilityassessmentschedule20whodas20inachronicpainpopulationbeingconsideredforchronicopioidtherapy
AT weedvf worldhealthorganizationdisabilityassessmentschedule20whodas20inachronicpainpopulationbeingconsideredforchronicopioidtherapy
AT myrtae worldhealthorganizationdisabilityassessmentschedule20whodas20inachronicpainpopulationbeingconsideredforchronicopioidtherapy
AT dibenedettodj worldhealthorganizationdisabilityassessmentschedule20whodas20inachronicpainpopulationbeingconsideredforchronicopioidtherapy